Dr. Wang was invited to attend BioChina 2025
From March 13th to 15th, 2025, BioChina was successfully held in Suzhou. As a representative of the cooperators, Dr. Wang was honored to take part in this professional event. During the event, he had the opportunity to meet many friends from universities, research institutions, and the pharmaceutical industry. Our anti-cancer projects, the NOD1/2 inhibitor and the 4-1BB agonist, attracted great attention from the participants. Looking forward to seeing a better one in 2026.
